- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Ayala Pharmaceuticals Inc (ADXS)
Ayala Pharmaceuticals Inc stock price live, this page displays OTC ADXS stock exchange data. View the ADXS premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Ayala Pharmaceuticals Inc real time stock price chart below.
What Is the Ayala Pharmaceuticals Inc Stock Price Today?
The Ayala Pharmaceuticals Inc stock price today is 0.03330.
What Is the Stock Symbol for Ayala Pharmaceuticals Inc?
The stock symbol for Ayala Pharmaceuticals Inc is ""ADXS.""
What Stock Exchange Does Ayala Pharmaceuticals Inc Trade On?
Ayala Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Ayala Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Ayala Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADXS quote. (ISIN: US0076244062)
What Is the Ayala Pharmaceuticals Inc Stock Price Today?
The Ayala Pharmaceuticals Inc stock price today is 0.03330.
What Is the Stock Symbol for Ayala Pharmaceuticals Inc?
The stock symbol for Ayala Pharmaceuticals Inc is ""ADXS.""
What Stock Exchange Does Ayala Pharmaceuticals Inc Trade On?
Ayala Pharmaceuticals Inc is listed and trades on the OTC Markets stock exchange.
Is Ayala Pharmaceuticals Inc a Good Stock to Buy?
Determining whether Ayala Pharmaceuticals Inc—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the ADXS quote. (ISIN: US0076244062)
OTC Markets
Currency in USD
0.03330
-0.01770(-34.71%)
Closed·
Fair Value
An estimate of a Ayala Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.03330
0.03330
52 wk Range
0.02000
0.80100
ADXS Scorecard
Full Analysis
Stock has taken a big hit over the last week
Earnings results expected today
1/2
Fair Value
An estimate of a Ayala Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
0.033300.03330
52 wk Range
0.020000.80100
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
N/A
(N/A)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
ADXS Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Ayala Pharmaceuticals's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Sell
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
Stock generally trades with high price volatility
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Sell
Technical Indicators
Sell
Moving Averages
Strong Sell
Ayala Pharmaceuticals Inc Company Profile
Ayala Pharmaceuticals, Inc., a clinical-stage oncology company, primarily focuses on developing and commercializing small molecule therapeutics for people living with rare tumors and aggressive cancers. The company’s lead candidates under development include AL102, an oral gamma secretase inhibitor for desmoid tumors; and aspacytarabine (BST-236), a novel proprietary anti-metabolite for first line treatment in unfit acute myeloid leukemia. Ayala Pharmaceuticals, Inc. is based in Wilmington, Delaware.
Compare ADXS to Peers and Sector
Metrics to compare | ADXS | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipADXSPeersSector | |
|---|---|---|---|---|
P/E Ratio | 0.0x | −3.0x | −0.5x | |
PEG Ratio | 0.00 | 0.00 | 0.00 | |
Price/Book | 0.0x | 1.5x | 2.6x | |
Price / LTM Sales | 0.0x | 8.6x | 3.3x | |
Upside (Analyst Target) | 0.0% | 199.2% | 38.7% | |
Fair Value Upside | Unlock | −0.9% | 5.0% | Unlock |
Earnings
Latest Release
May 30, 2025
EPS / Forecast
-- / --
Revenue / Forecast
-- / --
FAQ
What Stock Exchange Does Ayala Pharmaceuticals Trade On?
Ayala Pharmaceuticals is listed and trades on the OTC Markets stock exchange.
What Is the Stock Symbol for Ayala Pharmaceuticals?
The stock symbol for Ayala Pharmaceuticals is "ADXS."
What Is the Ayala Pharmaceuticals Market Cap?
As of today, Ayala Pharmaceuticals market cap is 1.64M.
What Is Ayala Pharmaceuticals's Earnings Per Share (TTM)?
The Ayala Pharmaceuticals EPS (TTM) is -7.99.
When Is the Next Ayala Pharmaceuticals Earnings Date?
Ayala Pharmaceuticals will release its next earnings report on 26 Aug 2025.
From a Technical Analysis Perspective, Is ADXS a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Sell.
How Many Times Has Ayala Pharmaceuticals Stock Split?
Ayala Pharmaceuticals has split 3 times.
How Many Employees Does Ayala Pharmaceuticals Have?
Ayala Pharmaceuticals has 21 employees.
What is the current trading status of Ayala Pharmaceuticals (ADXS)?
As of 27 Aug 2025, Ayala Pharmaceuticals (ADXS) is trading at a price of 0.03, with a previous close of 0.05. The stock has fluctuated within a day range of 0.03 to 0.03, while its 52-week range spans from 0.02 to 0.80.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.